INHA and tuberculosis: To test this possibility, we treated cells with isoniazid (INH), a frontline anti-TB drug which inhibits the essential enoyl-ACP reductase, InhA (Timmins and Deretic, 2006; Vilchèze and Jacobs, 2007).